Rapid Micro Biosystems Inc. (RPID) is scheduled to release fourth quarter and full year 2024 financial results before the market opens tomorrow (Feb.28, 2025).
This life sciences technology company manufactures and sells the "Growth Direct system" and related proprietary consumables, and value-added services to enable rapid microbial quality control, or MQC, testing in the manufacture of biologics and cell and gene therapies, vaccines, sterile injectables, and other healthcare products.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com